Sciele Pharma Inc: Premium Company Profile

Publication Date	December 2007
Publisher	Datamonitor
Product Type	Databook
Pages	57
ISBN Number	not applicable
Product Code	DAT09420

Price

£265.00
approximately: $532 | €333

PRINT £265 ($532 | €333)

Order above formats by FAX

Summary

Introduction

The company was founded in 1992 as First Horizon Pharmaceutical and later in 2006, changed its name to Sciele Pharma. The company's therapeutic focus is on cardiovascular/metabolic and women's health.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Sciele Pharma engages in sales, marketing and development of branded prescription products. The company currently markets and sells 16 products, 10 of which are actively promoted. The company markets products related to indications cardiovascular, diabetes and women's health.

Sciele Pharma's cardiovascular / diabetes related products include Altoprev, Fortamet, Nitrolingual, Triglide and sular and women's health related products include Optinate, Ostiva, Ponstel, Prenate Elite and Zovirax.

The company's total revenues increased at a CAGR of 26% during 2002-2006, from $115 million to $293 million. The company's biggest contributor to revenue growth during 2002-2006 was sales of cardiovascular / diabetes related products - Altoprev, Fortamet, Nitrolingual, Triglide and sular.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- AC Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Sales
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: Sciele Pharma - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Sciele Pharma - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: Sciele Pharma - Key Strategic Revenues, 2006-2010 ($ Mn)
- Table 1: Sciele Pharma - Key Facts
- Table 2: Sciele Pharma - Locations and Subsidiaries
- Table 3: Sciele Pharma - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: Sciele Pharma - Key Events Impacting Share Price Performance
- Table 5: Sciele Pharma - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Sciele Pharma - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 7: Sciele Pharma - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Sciele Pharma - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Sciele Pharma - Revenue Breakdown by Division, 2002-2006 ($ Mn)
- Table 10: Sciele Pharma - Marketed Products
- Table 11: Sciele Pharma - in-house Pipeline Products
- Table 12: Sciele Pharma - Collaboration Products
- Table 13: Sciele Pharma - Forecast Sales, 2006-2010 ($ Mn)
- Table 14: Sciele Pharma - Key Competitors
- Table 15: Sciele Pharma - Key Suppliers
- Table 16: Sciele Pharma - Key Clients
- Table 17: Sciele Pharma - Key Shareholders
- Table 18: Sciele Pharma - SWOT Analysis Summary
- Table 19: Sciele Pharma - Value Chain Analysis
- Table 20: Sciele Pharma - Scorecard
- Table 21: Sciele Pharma - Key Employees
- Table 22: Sciele Pharma - Financial and Operational Overview